Source:http://linkedlifedata.com/resource/pubmed/id/16828848
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2006-10-27
|
| pubmed:abstractText |
A variety of histologic grading systems for ovarian carcinoma have been used, but there is no widely accepted system. Binary grading systems are inherently superior to the more common three-grade systems because they are more reproducible and they correspond to the number of options in the binary treatment decision for which grade is considered important: the use of or withholding of chemotherapy.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0090-8258
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
103
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
703-8
|
| pubmed:meshHeading |
pubmed-meshheading:16828848-Cystadenocarcinoma, Serous,
pubmed-meshheading:16828848-Female,
pubmed-meshheading:16828848-Humans,
pubmed-meshheading:16828848-Middle Aged,
pubmed-meshheading:16828848-Neoplasm Staging,
pubmed-meshheading:16828848-Ovarian Neoplasms,
pubmed-meshheading:16828848-Peritoneal Neoplasms,
pubmed-meshheading:16828848-Prognosis,
pubmed-meshheading:16828848-Survival Rate
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum.
|
| pubmed:affiliation |
Department of Pathology, Washington Hospital Center, Washington, DC 20010, USA. jeffrey.d.seidman@medstar.net
|
| pubmed:publicationType |
Journal Article
|